Cargando…

65. INVASIVE HISTOPATHOLOGY DRIVES POOR OUTCOMES IN SURGICALLY RESECTED BRAIN METASTASES

BACKGROUND: Brain metastasis (BrM) patients treated with surgery and radiotherapy frequently experience local recurrence (LR), leptomeningeal metastasis (LM), and poor overall survival (OS). We sought to correlate the presence of invasive or circumscribed histopathological growth pattern, observed i...

Descripción completa

Detalles Bibliográficos
Autores principales: Dankner, Matthew, Caron, Maxime, Al-Saadi, Tariq, Yu, WenQing, Ouellet, Veronique, Uyen Le, Phuong, Ezzeddine, Rima, Neubarth, Noah, Savage, Paul, Zuo, Dongmei, Altoukhi, Huda, Bourque, Guillaume, Ragoussis, Jiannis, Diaz, Roberto, Park, Morag, Guiot, Marie-Christine, Lam, Stephanie, Petrecca, Kevin, Siegel, Peter M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7401331/
http://dx.doi.org/10.1093/noajnl/vdaa073.052
_version_ 1783566540244779008
author Dankner, Matthew
Caron, Maxime
Al-Saadi, Tariq
Yu, WenQing
Ouellet, Veronique
Uyen Le, Phuong
Ezzeddine, Rima
Neubarth, Noah
Savage, Paul
Zuo, Dongmei
Altoukhi, Huda
Bourque, Guillaume
Ragoussis, Jiannis
Diaz, Roberto
Park, Morag
Guiot, Marie-Christine
Lam, Stephanie
Petrecca, Kevin
Siegel, Peter M
author_facet Dankner, Matthew
Caron, Maxime
Al-Saadi, Tariq
Yu, WenQing
Ouellet, Veronique
Uyen Le, Phuong
Ezzeddine, Rima
Neubarth, Noah
Savage, Paul
Zuo, Dongmei
Altoukhi, Huda
Bourque, Guillaume
Ragoussis, Jiannis
Diaz, Roberto
Park, Morag
Guiot, Marie-Christine
Lam, Stephanie
Petrecca, Kevin
Siegel, Peter M
author_sort Dankner, Matthew
collection PubMed
description BACKGROUND: Brain metastasis (BrM) patients treated with surgery and radiotherapy frequently experience local recurrence (LR), leptomeningeal metastasis (LM), and poor overall survival (OS). We sought to correlate the presence of invasive or circumscribed histopathological growth pattern, observed in the BrM lesion and surrounding brain, with these outcomes, and to study molecular mediators of parenchymal invasion. METHODS: We assessed the HGP of H&E-stained slides from 164 surgically resected BrM from 147 patients. HGP was correlated with incidence of LR, LM and OS. Single-cell RNA sequencing (scRNAseq) was performed on three invasive HGP patients, sampling the metastasis center (MC) and surrounding brain (SB) outside of the contrast-enhancing region. Orthotopic patient-derived xenograft models (OPDX) were established from N=30 brain metastasis via intracranial propagation. RESULTS: 56/164 BrM specimens (34%) showed a circumscribed growth pattern between the tumor and adjacent brain (cHGP) while 108/164 (66%) showed significant invasion of tumor lobules or single cells into the brain parenchyma (iHGP). iHGP was associated with LR, LM and shortened OS in BrM patients. OPDX models of BrM retain features of patient BrM, including HGP. scRNAseq identified abundant cancer cells in SB that overexpressed a number of genes involved in cell survival, invasion and metastasis compared to matched cancer cells in MC. Validation of these targets with immunohistochemistry in patient and OPDX tissues revealed cold-inducible RNA binding protein (CIRBP) overexpression in iHGP patient and OPDX BrM. Modulation of CIRBP expression in OPDX and cell line models of iHGP BrM delayed BrM progression and extended OS. CONCLUSION: iHGP is a poor prognostic indicator in patients with surgically resected BrM, establishing HGP as an important prognostic factor that should be considered by clinicians treating BrM patients. We identify CIRBP as a functional mediator of this process.
format Online
Article
Text
id pubmed-7401331
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-74013312020-08-06 65. INVASIVE HISTOPATHOLOGY DRIVES POOR OUTCOMES IN SURGICALLY RESECTED BRAIN METASTASES Dankner, Matthew Caron, Maxime Al-Saadi, Tariq Yu, WenQing Ouellet, Veronique Uyen Le, Phuong Ezzeddine, Rima Neubarth, Noah Savage, Paul Zuo, Dongmei Altoukhi, Huda Bourque, Guillaume Ragoussis, Jiannis Diaz, Roberto Park, Morag Guiot, Marie-Christine Lam, Stephanie Petrecca, Kevin Siegel, Peter M Neurooncol Adv Supplement Abstracts BACKGROUND: Brain metastasis (BrM) patients treated with surgery and radiotherapy frequently experience local recurrence (LR), leptomeningeal metastasis (LM), and poor overall survival (OS). We sought to correlate the presence of invasive or circumscribed histopathological growth pattern, observed in the BrM lesion and surrounding brain, with these outcomes, and to study molecular mediators of parenchymal invasion. METHODS: We assessed the HGP of H&E-stained slides from 164 surgically resected BrM from 147 patients. HGP was correlated with incidence of LR, LM and OS. Single-cell RNA sequencing (scRNAseq) was performed on three invasive HGP patients, sampling the metastasis center (MC) and surrounding brain (SB) outside of the contrast-enhancing region. Orthotopic patient-derived xenograft models (OPDX) were established from N=30 brain metastasis via intracranial propagation. RESULTS: 56/164 BrM specimens (34%) showed a circumscribed growth pattern between the tumor and adjacent brain (cHGP) while 108/164 (66%) showed significant invasion of tumor lobules or single cells into the brain parenchyma (iHGP). iHGP was associated with LR, LM and shortened OS in BrM patients. OPDX models of BrM retain features of patient BrM, including HGP. scRNAseq identified abundant cancer cells in SB that overexpressed a number of genes involved in cell survival, invasion and metastasis compared to matched cancer cells in MC. Validation of these targets with immunohistochemistry in patient and OPDX tissues revealed cold-inducible RNA binding protein (CIRBP) overexpression in iHGP patient and OPDX BrM. Modulation of CIRBP expression in OPDX and cell line models of iHGP BrM delayed BrM progression and extended OS. CONCLUSION: iHGP is a poor prognostic indicator in patients with surgically resected BrM, establishing HGP as an important prognostic factor that should be considered by clinicians treating BrM patients. We identify CIRBP as a functional mediator of this process. Oxford University Press 2020-08-04 /pmc/articles/PMC7401331/ http://dx.doi.org/10.1093/noajnl/vdaa073.052 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Supplement Abstracts
Dankner, Matthew
Caron, Maxime
Al-Saadi, Tariq
Yu, WenQing
Ouellet, Veronique
Uyen Le, Phuong
Ezzeddine, Rima
Neubarth, Noah
Savage, Paul
Zuo, Dongmei
Altoukhi, Huda
Bourque, Guillaume
Ragoussis, Jiannis
Diaz, Roberto
Park, Morag
Guiot, Marie-Christine
Lam, Stephanie
Petrecca, Kevin
Siegel, Peter M
65. INVASIVE HISTOPATHOLOGY DRIVES POOR OUTCOMES IN SURGICALLY RESECTED BRAIN METASTASES
title 65. INVASIVE HISTOPATHOLOGY DRIVES POOR OUTCOMES IN SURGICALLY RESECTED BRAIN METASTASES
title_full 65. INVASIVE HISTOPATHOLOGY DRIVES POOR OUTCOMES IN SURGICALLY RESECTED BRAIN METASTASES
title_fullStr 65. INVASIVE HISTOPATHOLOGY DRIVES POOR OUTCOMES IN SURGICALLY RESECTED BRAIN METASTASES
title_full_unstemmed 65. INVASIVE HISTOPATHOLOGY DRIVES POOR OUTCOMES IN SURGICALLY RESECTED BRAIN METASTASES
title_short 65. INVASIVE HISTOPATHOLOGY DRIVES POOR OUTCOMES IN SURGICALLY RESECTED BRAIN METASTASES
title_sort 65. invasive histopathology drives poor outcomes in surgically resected brain metastases
topic Supplement Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7401331/
http://dx.doi.org/10.1093/noajnl/vdaa073.052
work_keys_str_mv AT danknermatthew 65invasivehistopathologydrivespooroutcomesinsurgicallyresectedbrainmetastases
AT caronmaxime 65invasivehistopathologydrivespooroutcomesinsurgicallyresectedbrainmetastases
AT alsaaditariq 65invasivehistopathologydrivespooroutcomesinsurgicallyresectedbrainmetastases
AT yuwenqing 65invasivehistopathologydrivespooroutcomesinsurgicallyresectedbrainmetastases
AT ouelletveronique 65invasivehistopathologydrivespooroutcomesinsurgicallyresectedbrainmetastases
AT uyenlephuong 65invasivehistopathologydrivespooroutcomesinsurgicallyresectedbrainmetastases
AT ezzeddinerima 65invasivehistopathologydrivespooroutcomesinsurgicallyresectedbrainmetastases
AT neubarthnoah 65invasivehistopathologydrivespooroutcomesinsurgicallyresectedbrainmetastases
AT savagepaul 65invasivehistopathologydrivespooroutcomesinsurgicallyresectedbrainmetastases
AT zuodongmei 65invasivehistopathologydrivespooroutcomesinsurgicallyresectedbrainmetastases
AT altoukhihuda 65invasivehistopathologydrivespooroutcomesinsurgicallyresectedbrainmetastases
AT bourqueguillaume 65invasivehistopathologydrivespooroutcomesinsurgicallyresectedbrainmetastases
AT ragoussisjiannis 65invasivehistopathologydrivespooroutcomesinsurgicallyresectedbrainmetastases
AT diazroberto 65invasivehistopathologydrivespooroutcomesinsurgicallyresectedbrainmetastases
AT parkmorag 65invasivehistopathologydrivespooroutcomesinsurgicallyresectedbrainmetastases
AT guiotmariechristine 65invasivehistopathologydrivespooroutcomesinsurgicallyresectedbrainmetastases
AT lamstephanie 65invasivehistopathologydrivespooroutcomesinsurgicallyresectedbrainmetastases
AT petreccakevin 65invasivehistopathologydrivespooroutcomesinsurgicallyresectedbrainmetastases
AT siegelpeterm 65invasivehistopathologydrivespooroutcomesinsurgicallyresectedbrainmetastases